Vaccine Company

🗓 Founded 2022👥 15 employees💰 Last funded Mar 2023
Biotechnology Research
LinkedIn
Vaccine Company, a wholly owned subsidiary of Eli Lilly and Company, was founded to bring next-generation antigen engineering to vaccine science. Our proprietary In Vivo Nanoparticle (IVN) technologies are designed to combine the strengths of mRNA and virus-like particle approaches to enable durable, multivalent immune responses to challenging viral targets. We are advancing a pipeline of preclinical and IND-enabling programs, led by a vaccine candidate for the prevention of infectious mononucleosis caused by Epstein-Barr virus.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Vaccine Company?
Vaccine Company has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Vaccine Company last raise funding?
The most recent investment in Vaccine Company recorded on gritt.io was in March 2023.
When was Vaccine Company founded?
Vaccine Company was founded in 2022.
What industry is Vaccine Company in?
Vaccine Company operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.